Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.
But more recently the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and healthcare division, the WSJ first reported.
In recent years, Philip Morris has also acquired Fertin Pharma, a nicotine gum maker, and OtiTopic, a respiratory drug maker.
And, in the second quarter of this year, the company took a $680 million impairment charge related to its wellness and healthcare division.
The news comes as the tobacco company continues to face resistance from public health groups.
Persons:
Philip Morris, it's, Concordia, Philip Morris's
Organizations:
Philip Morris International, Marlboro, Deutsche Bank, WSJ, Fertin Pharma, PMI, Concordia, UN, Assembly
Locations:
New York